🇺🇸 FDA
Pipeline program

Softisan 378, Cannabidiol

20U-0014

Phase 2 small_molecule active

Quick answer

Softisan 378, Cannabidiol for psychological disorders: PTSD; Anxiety disorders is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
psychological disorders: PTSD; Anxiety disorders
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials